Urologist Andrew von Eschenbach, MD, has been confirmed by the Senate as commissioner of the Food and Drug Administration.
Urologist Andrew von Eschenbach, MD, has been confirmed by the Senate as commissioner of the Food and Drug Administration. Dr. von Eschenbach has been the acting FDA commissioner since September 2005, and this action makes his position permanent.
Dr. von Eschenbach was formally nominated as commissioner in March, but his confirmation was delayed by objections from both Democratic and Republican senators over the agency’s delay of Plan B emergency contraceptives and the administration’s stance on drug reimportation.
Dr. von Eschenbach was the founding director of the Prostate Cancer Research Program at the University of Texas M.D. Anderson Cancer Center in Houston, and is the former director of the National Cancer Institute. He graduated from the Georgetown University School of Medicine and completed his residency in urologic surgery at Pennsylvania Hospital in Philadelphia, and was an instructor in urology at the University of Pennsylvania School of Medicine.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.